Dr. Victor Kiri has been appointed director of pharmacoepidemiology within Parexel International’s Clinical Research Services business. Dr. Kiri will be responsible for advising clients in the design and conduct of comparative observational studies, offering epidemiological analysis for compounds in development, and guiding strategic decisions regarding future areas of research and product development. “Regulatory pressures are increasing client demand for pharmacoepidemiologica...